Topotecan and PML: the limits of pharmaceutical industry research.
Learned
J
J
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002166:Camptothecin / Q000009:adverse effects* / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic; D003254:Consumer Advocacy; D017277:Drug Approval; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D015658:HIV Infections / Q000188:drug therapy; D006297:Health Services Accessibility; D006801:Humans; D007577:JC Virus / Q000187:drug effects; D007968:Leukoencephalopathy, Progressive Multifocal / Q000188:drug therapy* / Q000209:etiology; D010051:Ovarian Neoplasms / Q000188:drug therapy; D019772:Topotecan
D000970:Antineoplastic Agents; D019772:Topotecan; D002166:Camptothecin